Helen Morrin

1.1k citations
28 papers · 784 · h-index 16

Impact in

  • Cancer Research top 10%
    • Cancer, Hypoxia, and Metabolism
    • Cancer-related molecular mechanisms research
  • Oncology top 10%
    • Cancer Cells and Metastasis
    • Lymphatic System and Diseases
    • Viral-associated cancers and disorders

Papers in

  • Oncology 9
    • Lymphatic System and Diseases 2
    • Colorectal Cancer Treatments and Studies 2
  • Molecular Biology 7
    • Molecular Biology Techniques and Applications 2
    • RNA Research and Splicing 2
Co-authors
Bridget A. Robinson (19 shared papers)Margaret J. Currie (12 shared papers)Stephen B. Fox (4 shared papers)Sarah Gunningham (4 shared papers)Gabi U. Dachs (11 shared papers)Prudence A. E. Scott (1 shared paper)Margreet C.M. Vissers (8 shared papers)John F. Pearson (7 shared papers)
Journals
Frontiers in Oncology (4 papers)BMC Cancer (2 papers)Biopreservation and Biobanking (2 papers)Experimental Dermatology (1 paper)Clinical Cancer Research (1 paper)
Partner nations
New ZealandAustraliaUnited States

In The Last Decade

Helen Morrin

25 papers receiving 764 citations

Peers

Helen Morrin
Comparison fields: 5 of 97
  • Cancer Research 190
  • Oncology 295
  • Pathology and Forensic Medicine 96
  • Nutrition and Dietetics 71
  • Molecular Biology 277
Replace Anjian Xu with:
Anjian Xu China
Wilma Jogunoori United States
Anna Woloszynska‐Read United States
Maider Ibarrola‐Villava Spain
Jie Zha China
Sarah A. Best Australia
Maria Teresa Landi United States
Yongping Cui China
Deli Hong United States
Putao Cen United States
Helen Morrin relative to Anjian Xu China Anjian Xu's profile →
Citations per field
00.5×1.5×2.2×
Anjian Xu · 1×
Citations per year

Countries citing papers authored by Helen Morrin

Since Specialization
Citations

This map shows the geographic impact of Helen Morrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Morrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Morrin more than expected).

Fields of papers citing papers by Helen Morrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Morrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Morrin. The network helps show where Helen Morrin may publish in the future.

Co-authors

The 25 scholars most cited alongside Helen Morrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Morrin Line = papers co-authored together Helen Morrin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression
The Journal of Pathology ·Vickie Hanrahan, Margaret J. Currie, Sarah Gunningham, Helen Morrin, Prudence A. E. Scott, Bridget A. Robinson, Stephen B. Fox
2003187
2
Cytomegalovirus and Epstein-Barr Virus in Breast Cancer
PLoS ONE ·Ann Richardson, Margaret J. Currie, Bridget A. Robinson, Helen Morrin, Yen Phung, John F. Pearson, Trevor P. Anderson, John D. Potter, Logan C. Walker
201580
3
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1α) and the HIF-1α target gene DEC1, but not lymph node metastasis in primary human breast carcinomas
Journal of Clinical Pathology ·Margaret J. Currie, Vickie Hanrahan, S P Gunningham, Helen Morrin, Chris Frampton, Chengcheng Han, Bridget A. Robinson, Stephen B. Fox
200458
4
Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity
Human Pathology ·Margaret J. Currie, Brooke Beardsley, Gavin Harris, Sarah Gunningham, Gabi U. Dachs, B. Dijkstra, Helen Morrin, J. Elisabeth Wells, Bridget A. Robinson
201257
5
Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels
BMC Cancer ·Elizabeth J. Campbell, Gabi U. Dachs, Helen Morrin, Valerie Davey, Bridget A. Robinson, Margreet C.M. Vissers
201953
6
The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16INK4a Expression
Frontiers in Oncology ·Janice A. Royds, Anna P. Pilbrow, Antonio Ahn, Helen Morrin, Chris Frampton, I. Alasdair Russell, Christine S. Moravec, Wendy E. Sweet, W.H. Wilson Tang, Margaret J. Currie, Noelyn Hung, Tania L. Slatter
201637
7
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
Cell Death and Disease ·Marina Kazantseva, Sunali Mehta, Ramona A. Eiholzer, Grégory Gimenez, Sara Bowie, Hamish G. Campbell, Ashley L. Reily-Bell, Imogen Roth, Sankalita Ray, Catherine J. Drummond, Glen Reid, Sebastien M. Joruiz, Anna Wiles, Helen Morrin, Karen L. Reader, Noelyn Hung, Margaret A. Baird, Tania L. Slatter, Antony W. Braithwaite
201933
8
The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
Frontiers in Oncology ·Christina Wohlrab, Margreet C.M. Vissers, Elisabeth Phillips, Helen Morrin, Bridget A. Robinson, Gabi U. Dachs
201832
9
Caspase Recruitment Domain-Containing Protein 15 Mutations in Patients with Colorectal Cancer
Cancer Research ·Rebecca L Roberts, Richard B. Gearry, Melanie D.E. Allington, Helen Morrin, Bridget A. Robinson, Frank Frizelle
200631
10
Breast cancer and cytomegalovirus
Clinical & Translational Oncology ·Ann Richardson, Logan C. Walker, Brian Cox, Halvor Rollag, Bridget A. Robinson, Helen Morrin, John F. Pearson, John D. Potter, Margaret Paterson, Heljä‐Marja Surcel, ­Eero Pukkala, Margaret J. Currie
201925
11
Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study
Frontiers in Oncology ·Gabi U. Dachs, Jamish Gandhi, Christina Wohlrab, Anitra C. Carr, Helen Morrin, Juliet M. Pullar, Simone Bayer, Tim Eglinton, Bridget A. Robinson, Margreet C.M. Vissers
202123
12
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients
Histopathology ·Zachary F. Gerring, John F. Pearson, Helen Morrin, Bridget A. Robinson, Gavin Harris, Logan C. Walker
201523
13
APC Mutations Are Not Confined to Hotspot Regions in Early-Onset Colorectal Cancer
Cancers ·Alan Aitchison, Christopher Hakkaart, Robert C. Day, Helen Morrin, Frank Frizelle, Jacqueline I. Keenan
202019
14
The Christchurch Tissue Bank to support cancer research.
PubMed ·Helen Morrin, Sarah Gunningham, Margaret J. Currie, Gabi U. Dachs, Stephen B. Fox, Bridget A. Robinson
200518
15
The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis
Clinical Cancer Research ·Leonid L. Nikitenko, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen Morrin, Andrea Pellagatti, Margaret Rees, Adrian L. Harris, Stephen B. Fox
201317
16
Low Vitamin C Status in Patients with Cancer Is Associated with Patient and Tumor Characteristics
Nutrients ·Rebecca White, Maria Nonis, John F. Pearson, Eleanor R. Burgess, Helen Morrin, Juliet M. Pullar, Emma Spencer, Margreet C.M. Vissers, Bridget A. Robinson, Gabi U. Dachs
202017
17
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom
Biopreservation and Biobanking ·Clare M. Allocca, Marianna J. Bledsoe, Monique Albert, Sergey V. Anisimov, Elena Bravo, Marta G. Castelhano, Yehudit Cohen, Mieke De Wilde, Koh Furuta, Zisis Kozlakidis, Dunja Martin, Anabela Martins, Shannon J. McCall, Helen Morrin, Rebecca S. Pugh, Brent Schacter, Daniel Simeon‐Dubach, Emma Snapes
202014
18
Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival
Frontiers in Oncology ·Eleanor R. Burgess, Rebekah Crake, Elisabeth Phillips, Helen Morrin, Janice A. Royds, Tania L. Slatter, George A. R. Wiggins, Margreet C.M. Vissers, Bridget A. Robinson, Gabi U. Dachs
202211
19
Sustaining a Biobank Through a Series of Earthquake Swarms: Lessons Learned from our New Zealand Experience
Biopreservation and Biobanking ·Helen Morrin, Bridget A. Robinson
201311
20
Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine
Scientific Reports ·Rebekah Crake, Eleanor R. Burgess, George A. R. Wiggins, Nicholas J. Magon, Andrew B. Das, Margreet C.M. Vissers, Helen Morrin, Janice A. Royds, Tania L. Slatter, Bridget A. Robinson, Elisabeth Phillips, Gabi U. Dachs
20229

About Helen Morrin

Helen Morrin is a scholar working on Oncology, Molecular Biology, Cancer Research, Nutrition and Dietetics and Genetics, having authored 28 papers that have together received 784 indexed citations. Recurring topics across this work include Vitamin C and Antioxidants Research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Glioma Diagnosis and Treatment (3 papers), Lymphatic System and Diseases (2 papers), Molecular Biology Techniques and Applications (2 papers), RNA Research and Splicing (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Cancer Research (190 citations), Oncology (295 citations), Pathology and Forensic Medicine (96 citations), Nutrition and Dietetics (71 citations) and Molecular Biology (277 citations). Helen Morrin has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include Bridget A. Robinson, Margaret J. Currie, Stephen B. Fox, Sarah Gunningham, Gabi U. Dachs, Prudence A. E. Scott, Margreet C.M. Vissers, John F. Pearson, Logan C. Walker and Ann Richardson. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Biopreservation and Biobanking, Experimental Dermatology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anjian XuBreakdown of academic impact, for papers by Wilma JogunooriBreakdown of academic impact, for papers by Anna Woloszynska‐ReadBreakdown of academic impact, for papers by Maider Ibarrola‐VillavaBreakdown of academic impact, for papers by Jie ZhaBreakdown of academic impact, for papers by Sarah A. BestBreakdown of academic impact, for papers by Maria Teresa LandiBreakdown of academic impact, for papers by Yongping CuiBreakdown of academic impact, for papers by Deli HongBreakdown of academic impact, for papers by Putao Cen